Patients/populationInterventionComparisonOutcomes
Patients with central venous access devices and neutropenia or neutropenic sepsis, without an identified bacterium.Empiric vancomycin, teicoplanin, linezolid in addition to first line antibioticsFirst-line, broad spectrum antibiotics
  • Death
  • critical care,
  • Length of stay
  • Line preservation / “catheter remains in situ”
  • Antibiotic resistance
  • Proven Bacteraemia
  • Toxicity

From: Initial Treatment: guideline chapter six

Cover of Neutropenic Sepsis: Prevention and Management of Neutropenic Sepsis in Cancer Patients
Neutropenic Sepsis: Prevention and Management of Neutropenic Sepsis in Cancer Patients.
NICE Clinical Guidelines, No. 151.
National Collaborating Centre for Cancer (UK).
Copyright © National Collaborating Centre for Cancer, 2012.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.